Underlying prothrombotic states in pregnancy associated cerebral venous thrombosis

被引:20
作者
Aaron, S. [1 ]
Alexander, M. [1 ]
Maya, T. [1 ]
Mathew, V. [1 ]
Goel, M. [1 ]
Nair, S. C. [2 ]
Mammen, J. [2 ]
Vikram, M. [3 ]
机构
[1] Christian Med Coll & Hosp, Dept Neurol Sci, Neurol Unit, Vellore 632004, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Dept Clin Pathol, Vellore 632004, Tamil Nadu, India
[3] Christian Med Coll & Hosp, Dept Hematol, Vellore 632004, Tamil Nadu, India
关键词
Cerebral venous thrombosis; factor V leiden; factor VIII; hyperhomocysteinemia; MTHFR; protein C; protein S; ACTIVATED PROTEIN-C; V-LEIDEN MUTATION; VEIN-THROMBOSIS; RISK; WOMEN; THROMBOEMBOLISM; COAGULATION; PREVALENCE; RESISTANCE; VARIANT;
D O I
10.4103/0028-3886.68676
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The exact pathogenesis of pregnancy associated cerebral venous thrombois is still unsettled. Aims: To identify possible inherited and acquired prothrombotic risk factors and also identify the factors associated with mortality in pregnancy associated CVT. Settings and Design: Prospective cohort study to identify prothrombotic risk factors and case control study of influence of local traditional practice of puerperal water restriction on postpartum CVT. Materials and Methods: Consecutive patients with pregnancy associated CVT seen over a period of three years. Thrombotic workup included genetic markers, protein assays, and other factors. Statistical Analysis: Univariate and chi-square analysis. Results: Of the 41 patients studied during the study period, 71% of patient had a single and 34% had multiple prothrombotic risk factors. Methylene tetrahydro-folate reductase (MTHFR) heterozygosity (19.5%) and factor V Leiden heterozygous (7.3%) were the commonest genetic markers. Hyperhomocysteinemia (34%) and elevated factor VIII levels (14.6%) were the other important risk factors. In this cohort the mortality was 17%. Mortality increased by odds of 1.3 for every additional prothrombotic marker. The factors associated with increased mortality included: status epileptics (P = 0.05, OR 13.2, 95% CI 1.002 - 173), deep venous system involvement (P = 0.016, OR 9.64, 95% CI 1.53 - 60.6), presence of midline shift (P = 0.012, OR 24.7, 95% CI 2.05 - 29.8) and diffuse cerebral edema (P = 0.006, OR 14.5, 95% CI 2.18- 96.4). The traditional practice of decrease intake of water during puerperium was significant in woman with pregnancy associated CVT when compared to control subjects (P < 0.02). Conclusion: In patients with pregnancy associated CVT, prothrombotic markers can be multiple and are associated with increased odds of mortality. Deep venous system involvement, presence of midline shift and diffuse cerebral edema increased mortality. Peuperial water restriction may be a modifiable risk factor.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 30 条
[1]   Cerebral venous thrombosis due to homozygous factor V Leiden mutation [J].
Aaron, S. ;
Alexander, M. ;
Thomas, M. ;
George, B. ;
Mammen, J. .
NEUROLOGY INDIA, 2009, 57 (01) :91-91
[2]   An Epidemiological Study of Hemiplegia due to Stroke in South India [J].
Abraham, J. ;
Rao, P. S. S. ;
Inbaraj, S. G. ;
Shetty, G. ;
Jose, C. J. .
STROKE, 1970, 1 (06) :477-481
[3]   Strokes in the Young [J].
Abraham, Jacob ;
Shetty, G. ;
Jose, C. J. .
STROKE, 1971, 2 (03) :258-267
[4]   Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians [J].
Angeline, T ;
Bentley, HA ;
Hawk, AB ;
Manners, RJ ;
Mokash, HA ;
Jeyaraj, N ;
Tsongalis, GJ .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2005, 79 (01) :9-13
[5]   Cerebral venous thrombosis - Clinical outcome and systematic screening of prothrombotic factors [J].
Cakmak, S ;
Derex, L ;
Berruyer, M ;
Nighoghossian, N ;
Philippeau, F ;
Adeleine, P ;
Hermier, M ;
Froment, JC ;
Trouillas, P .
NEUROLOGY, 2003, 60 (07) :1175-1178
[6]   Causes and predictors of death in cerebral venous thrombosis [J].
Canhao, PC ;
Ferro, JM ;
Lindgren, AG ;
Bousser, MG ;
Stam, J ;
Barinagarrementeria, F .
STROKE, 2005, 36 (08) :1720-1725
[7]   Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK Indian Asians [J].
Chambers, JC ;
Ireland, H ;
Thompson, E ;
Reilly, P ;
Obeid, OA ;
Refsum, H ;
Ueland, P ;
Lane, DA ;
Kooner, JS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) :2448-2452
[8]   DEVELOPMENT OF RESISTANCE TO ACTIVATED PROTEIN-C DURING PREGNANCY [J].
CUMMING, AM ;
TAIT, RC ;
FILDES, S ;
YOONG, A ;
KEENEY, S ;
HAY, CRM .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) :725-727
[9]   Venous thromboembolism in young patients from Western India: A study [J].
Ghosh, K ;
Shetty, S ;
Madkaikar, M ;
Pawar, A ;
Nair, S ;
Khare, A ;
Pathare, A ;
Jijina, F ;
Mohanty, D .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (02) :158-165
[10]  
GRIFFIN JH, 1982, BLOOD, V60, P261